Vaccines, global health and social equity
- PMID: 19308074
- DOI: 10.1038/icb.2009.15
Vaccines, global health and social equity
Abstract
Mortality rates of children less than 5 years old range from <10 per 1000 live births in industrialized countries to >100 in the world's poorest countries. The fact that in New York City infant mortality fell from approximately 140 deaths per 1000 live births in 1900 to <60 per 1000 by 1930 indicates what can be achieved through improvements in public health, such as the provision of clean piped water, sewage disposal and fresh refrigeration. For children living in impoverished conditions today, excess mortality is largely due to infectious diseases for which there are effective vaccines. Thus, certain specific vaccines can reduce mortality and morbidity, improve quality of life and contribute to economic development. However, because many vaccines and the means to deliver them are beyond the financial resources of countries with the highest childhood mortality rates, strategies have been devised to provide vaccines to the most needy populations. These strategies include initiatives by the Global Alliance for Vaccines and Immunization, the International Finance Facility for Immunization and the Advanced Market Commitment, which together with various governments, international agencies and charitable foundations are providing funds to make life-saving vaccines available to the world's most needy children.
Similar articles
-
New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.Vaccine. 2003 Jan 30;21(7-8):587-92. doi: 10.1016/s0264-410x(02)00564-9. Vaccine. 2003. PMID: 12531322
-
Contribution of the GAVI Alliance to improving health and reducing poverty.Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2743-7. doi: 10.1098/rstb.2011.0040. Philos Trans R Soc Lond B Biol Sci. 2011. PMID: 21893535 Free PMC article.
-
Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.Health Aff (Millwood). 2016 Feb;35(2):242-9. doi: 10.1377/hlthaff.2015.1080. Health Aff (Millwood). 2016. PMID: 26858376
-
Challenges for nationwide vaccine delivery in African countries.Int J Health Econ Manag. 2018 Jun;18(2):197-219. doi: 10.1007/s10754-017-9229-5. Epub 2017 Oct 19. Int J Health Econ Manag. 2018. PMID: 29047019 Review.
-
Strategies to maintain health in the Third World.Trop Med Parasitol. 1991 Dec;42(4):428-32. Trop Med Parasitol. 1991. PMID: 1796244 Review.
Cited by
-
Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).BMC Public Health. 2015 Nov 30;15:1198. doi: 10.1186/s12889-015-2521-8. BMC Public Health. 2015. PMID: 26621528 Free PMC article.
-
The case for launch of an international DNA-based birth cohort study.J Glob Health. 2011 Jun;1(1):39-45. J Glob Health. 2011. PMID: 23198101 Free PMC article.
-
Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.Front Immunol. 2013 Apr 2;4:81. doi: 10.3389/fimmu.2013.00081. eCollection 2013. Front Immunol. 2013. PMID: 23565115 Free PMC article.
-
The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis.Clin Infect Dis. 2012 Dec;55 Suppl 4(Suppl 4):S215-24. doi: 10.1093/cid/cis761. Clin Infect Dis. 2012. PMID: 23169934 Free PMC article.
-
Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.PLoS One. 2016 Feb 26;11(2):e0149848. doi: 10.1371/journal.pone.0149848. eCollection 2016. PLoS One. 2016. PMID: 26919709 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical